AstraZeneca Publishes Phase III Data Showing Brezt...
Category : Clinical Trial Update 16 February 2026Full Phase III results from the KALOS and LOGOS trials, published in The Lancet Respiratory Medicine...
Full Phase III results from the KALOS and LOGOS trials, published in The Lancet Respiratory Medicine...
Novartis announced final results from the Phase III ALIGN study evaluating Vanrafia (atrasentan) in...
Aramis Biotechnologies and the Biologics Manufacturing Centre (BMC) announced completion of formulat...
Chugai Pharmaceutical has presented new data from Part C of the Phase I/II NXTAGE study evaluating N...
VectorY Therapeutics has dosed the first participant in its Phase I/II PIONEER-ALS trial evaluating...